Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo
NCT04408014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18901
Last updated 2024-02-15
Summary
Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo
Conditions
- COVID
- SARS-CoV 2
Interventions
- DIAGNOSTIC_TEST
-
Serological test
IgM and IgG for SARS-CoV-2
- DIAGNOSTIC_TEST
-
Nasopharyngeal Swab
PCR for SARS-CoV-2
- DIAGNOSTIC_TEST
-
Oropharyngeal Swab
PCR for SARS-CoV-2
Sponsors & Collaborators
-
Butantan Institute
lead OTHER_GOV
Principal Investigators
-
Alexander R Precioso, MD, PhD · Instituto butantan
Eligibility
- Min Age
- 6 Months
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2020-07-15
- Completion
- 2020-07-30
Countries
- Brazil
Study Locations
More Related Trials
-
SARS-COV2 Pandemic Serosurvey and Blood Sampling
NCT04334954 ·Status: COMPLETED
-
Epidemiological Study of the COVID-2019 in Participating Organizations.
NCT05043142 ·Status: COMPLETED
-
Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
NCT04668235 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Patients With COVID-19 With Convalescent Plasma
NCT04415086 ·Status: COMPLETED ·Phase: PHASE2
-
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.
NCT04259892 ·Status: COMPLETED
-
A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)
NCT04758273 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers
NCT04405466 ·Status: COMPLETED
-
Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)
NCT04560881 ·Status: COMPLETED ·Phase: PHASE3
-
Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19
NCT04452812 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effects of Early Use of Nitazoxanide in Patients With COVID-19
NCT04552483 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
NCT04928495 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19
NCT04348409 ·Status: COMPLETED ·Phase: NA
-
Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection
NCT04409184 ·Status: WITHDRAWN
-
Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years
NCT04470609 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enriched Heparin Anti COVID-19 Trial
NCT04743011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19
NCT05365321 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
NCT05033145 ·Status: COMPLETED ·Phase: PHASE3
-
Collection of Anti-SARS-CoV-2 Immune Plasma
NCT04344977 ·Status: COMPLETED
-
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)
NCT04383574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient
NCT05489874 ·Status: UNKNOWN
-
Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population
NCT04561102 ·Status: COMPLETED
-
Surveillance of Individuals Following SARS-CoV-2 Infection
NCT04383444 ·Status: COMPLETED
-
Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19
NCT04423861 ·Status: UNKNOWN ·Phase: PHASE3
-
Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients
NCT04584606 ·Status: UNKNOWN
-
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19
NCT05038449 ·Status: UNKNOWN ·Phase: NA